Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-25-000413
Filing Date
2025-01-14
Accepted
2025-01-14 18:57:09
Documents
1
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3897
  Complete submission text file 0001654954-25-000413.txt   5373
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Issuer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DERMATA THERAPEUTICS, INC. 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address
Nardo Christopher J. (Reporting) CIK: 0001870247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40739 | Film No.: 25530546